These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29203397)

  • 21. Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart.
    Hofmann F; Fabritz L; Stieber J; Schmitt J; Kirchhof P; Ludwig A; Herrmann S
    Cardiovasc Res; 2012 Aug; 95(3):317-26. PubMed ID: 22652004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological Twisting: Electrical Alternans in Congenital Dilated Cardiomyopathy.
    Arif R; Hussain A; Dhillon S
    Circ Arrhythm Electrophysiol; 2017 Feb; 10(2):. PubMed ID: 28148547
    [No Abstract]   [Full Text] [Related]  

  • 24. Contributions of HERG K+ current to repolarization of the human ventricular action potential.
    Fink M; Noble D; Virag L; Varro A; Giles WR
    Prog Biophys Mol Biol; 2008; 96(1-3):357-76. PubMed ID: 17919688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antiarrhythmics and hypokalemia on the rate adaptation of cardiac repolarization.
    Osadchii OE
    Scand Cardiovasc J; 2018 Aug; 52(4):218-226. PubMed ID: 29798684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of suppression of the inward rectifier current in terminal action potential repolarization in the failing heart.
    Klein MG; Shou M; Stohlman J; Solhjoo S; Haigney M; Tidwell RR; Goldstein RE; Flagg TP; Haigney MC
    Heart Rhythm; 2017 Aug; 14(8):1217-1223. PubMed ID: 28396172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium channel down-regulation in heart failure.
    Näbauer M; Kääb S
    Cardiovasc Res; 1998 Feb; 37(2):324-34. PubMed ID: 9614489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of cardiac potassium channels.
    Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
    Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired epicardial activation-repolarization coupling contributes to the proarrhythmic effects of hypokalaemia and dofetilide in guinea pig ventricles.
    Osadchii OE
    Acta Physiol (Oxf); 2014 May; 211(1):48-60. PubMed ID: 24533513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes.
    Nuss HB; Marbán E; Johns DC
    J Clin Invest; 1999 Mar; 103(6):889-96. PubMed ID: 10079110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico assessment of drug safety in human heart applied to late sodium current blockers.
    Trenor B; Gomis-Tena J; Cardona K; Romero L; Rajamani S; Belardinelli L; Giles WR; Saiz J
    Channels (Austin); 2013; 7(4):249-62. PubMed ID: 23696033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of the inward rectifier K+ current during the action potential of guinea pig ventricular myocytes.
    Ibarra J; Morley GE; Delmar M
    Biophys J; 1991 Dec; 60(6):1534-9. PubMed ID: 1777570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials.
    Calloe K; Di Diego JM; Hansen RS; Nagle SA; Treat JA; Cordeiro JM
    Biochem Pharmacol; 2016 May; 108():36-46. PubMed ID: 27002181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological effects of protopine in cardiac myocytes: inhibition of multiple cation channel currents.
    Song LS; Ren GJ; Chen ZL; Chen ZH; Zhou ZN; Cheng H
    Br J Pharmacol; 2000 Mar; 129(5):893-900. PubMed ID: 10696087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Abnormal Serum Potassium Levels with Arrhythmias and Cardiovascular Mortality: a Systematic Review and Meta-Analysis of Observational Studies.
    Hoppe LK; Muhlack DC; Koenig W; Carr PR; Brenner H; Schöttker B
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):197-212. PubMed ID: 29679302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early afterdepolarizations promote transmural reentry in ischemic human ventricles with reduced repolarization reserve.
    Dutta S; Mincholé A; Zacur E; Quinn TA; Taggart P; Rodriguez B
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):236-48. PubMed ID: 26850675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium Channel Remodeling in Heart Disease.
    Algalarrondo V; Nattel S
    Card Electrophysiol Clin; 2016 Jun; 8(2):337-47. PubMed ID: 27261825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
    Crumb WJ; Vicente J; Johannesen L; Strauss DG
    J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
    Ducroq J; Rouet R; Sallé L; Puddu PE; Repessé Y; Ghadanfar M; Ducouret P; Gérard JL
    Eur J Pharmacol; 2006 Feb; 532(3):279-89. PubMed ID: 16480976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.